AzTrials
AzTrials

Periapical LesionAINCT07319182

Accuracy of Artificial Intelligence Technology in Detecting Periapical Lesions in Human Teeth.

A study testing Cone beam computed tomography and artificial intelligence software in people with Periapical Lesion, run by Future University in Egypt at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aims to evaluate the accuracy of using Artificial intelligence software in detecting the presence of periapical lesion compared to CBCT imaging. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Periapical Lesion
What is being tested?
Cone beam computed tomography and artificial intelligence software
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteEgypt
Study dates
6 Dec 2024to 21 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • All patients must be medically free from any systemic disease that can affect root canal treatment.
  • 18 to 50 years old patients with permanent teeth presenting with periapical pathosis.
  • No sex predilection.
  • All patients must have good oral hygiene.
  • Restorable teeth
  • Positive patient's acceptance for participating in the study.
  • Patients able to sign informed consent

Who cannot join

  • Patients above 50 years or patients below 18 years.
  • Patients with very poor oral hygiene.
  • Pregnant women after taking detailed history and pregnancy test must be in the first visit.
  • Psychologically disturbed patients.
  • Teeth that have:
  • Periodontally affected with grade 2 or 3 mobility.
  • Not restorable teeth.
  • Abnormal anatomy and calcified canals

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Future University in Egypt

    Cairo

Other trials in Egypt

About this study

Official title: Accuracy of Artificial Intelligence Technology in Detecting Periapical Lesions in Human Teeth. Diagnostic Accuracy Experimental Study.

Aims to evaluate the accuracy of using Artificial intelligence software in detecting the presence of periapical lesion compared to CBCT imaging.

Read the detailed description

In this research, patients referred to endodontic department in the university will undergo clinical examination (percussion, palpation) tests. These will be recorded. Then the patient will undergo a periapical radiograph to detect the presence of periapical lesion. Patients with periapical lesions will then undergo a cone beam computed tomography and this scan will be uploaded into the Artificial intelligence software to detect the accuracy of the software in detecting the presence of the periapical lesion. Any patient with a periapical lesion in need of root canal treatment will undergo the treatment.

Being tested
Cone beam computed tomography, artificial intelligence software
Keywords
artificial intelligence, periapical lesion, CBCT

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cone beam computed tomographyOther

    Cone beam computed tomography scans to detect the presence of periapical lesion by specialized investigators.

  • artificial intelligence softwareOther

    artificial intelligence software that aids in diagnosis in dentistry

Study groups in NCT07319182
Study groupRoleWhat they receive
cone beam computed tomographyActive comparatordetecting radiolucent periapical lesions using cone beam computed tomography
Receives: Other: Cone beam computed tomography
artificial intelligence softwareActive comparatorCone beam CT scan will be uploaded to artificial intelligence software to ensure that the software will detect radiolucent periapical lesion compared to Cone beam CT scans.
Receives: Other: artificial intelligence software

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CBCT scans

    Presence of periapical lesion on CBCT scans

    Measured: 1 year

Secondary outcomes (1)
  1. Accuracy of Artificial intelligence software

    Comparing results from CBCT scans to Artificial intelligence software in detection of periapcial lesions.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2026
  2. Study start6 Dec 2024
  3. Primary completion1 Nov 2025
  4. Study completion21 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Sequential
Masking
Single blind
Who is masked
Investigator
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07319182
Sponsor's protocol ID
(52)/11-2024
Acronym
AI
Status last verified
Dec 2025
First submitted
21 Dec 2025
Last updated
6 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Cone beam computed tomography and artificial intelligence software in people with Periapical Lesion, run by Future University in Egypt at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CBCT scans (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in